Эффективность программ химиотерапии первой линии при различных стадиях лимфомы Ходжкина

Kamil’ Daniyalovich Kaplanov, А. Л. Шипаева, В А Васильева et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2012

Today for the treatment of Hodgkin’s lymphoma schemes of varying intensity are used. The choice of first-line chemotherapy for Hodgkin’s lymphoma depends on the stage of the disease and risk factors. We present the results of patients with newly diagnosed Hodgkin’s lymphoma in the period from 2003 to 2008 (n = 244), treated in the Department of Hematology Volgograd Regional Clinical Cancer Dispensary No. 1. The early stages of Hodgkin’s lymphoma without risk factors were characterized by the best results with minimal adverse effects (3-year overall survival rate in this group is 95 %, free from treatment failure 90 %). In patients with early stages of Hodgkin’s lymphoma with risk factors there was no significant difference between ABVD and BEACOPP-basis schemes in terms of overall survival (3-year OS 80 % in each group) and free from treatment failure survival (3-year FFTF 76 % and 52 % respectively, p = 0,73). There is a slight tendency to improve OS and FFTF in these patients when treated with BEACOPP-escalated and BEACOPP-14, but the lack of patients can’t prove the benefit of these programs. Among patients with advanced Hodgkin’s lymphoma the greatest differences in OS were observed between those who received BEACOPP-basis and intensive variants of BEACOPP scheme (OS rate 74 % and 95 % (p < 0,01), FFTF 55 % and 72 % (p = 0,05) respectively.

Cited by 0 works.

Authors